Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Technology
2.3.2 Market Size By Disease Type
2.3.3 Market Size By End-User
2.3.4 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Adoption & Operational Metrics
4.1.1 Percentage (%) of healthcare facilities adopting rapid or point-of-care diagnostics
4.1.2 Number of tests performed per year globally and regionally
4.1.3 Average turnaround time (hours/days) for infectious disease testing
4.1.4 Laboratory utilization rate (%) and workflow efficiency
4.2 Technology & Performance Metrics
4.2.1 Diagnostic accuracy (%) and sensitivity/specificity across technologies
4.2.2 Adoption rate (%) of molecular vs immunoassay methods
4.2.3 Time-to-result (hours) for different test types
4.2.4 Percentage (%) of tests integrated with digital reporting or eHealth platforms
4.3 Regulatory & Compliance Metrics
4.3.1 Average regulatory approval timelines (months) for diagnostic kits
4.3.2 Number (%) of diagnostics cleared by major authorities (FDA, CE, etc.)
4.3.3 Percentage (%) of diagnostics under accelerated or emergency approval pathways
4.3.4 Compliance rate (%) with ISO and other international standards
4.4 Distribution & Accessibility Metrics
4.4.1 Number of diagnostic facilities with access to advanced infectious disease testing
4.4.2 Geographic penetration (%) in urban vs rural healthcare centers
4.4.3 Supply chain efficiency (%) for test kits and reagents
4.4.4 Adoption rate (%) of telemedicine or remote diagnostic support
5. Infectious Disease Diagnostics Market Segmental Analysis & Forecast, By Technology, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 Molecular Diagnostics
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Immunoassays
5.4 Microbiological Culture
5.5 Point-of-Care Tests
5.6 Others
6. Infectious Disease Diagnostics Market Segmental Analysis & Forecast, By Disease Type, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Bacterial
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Viral
6.4 Fungal
6.5 Parasitic
6.6 Others
7. Infectious Disease Diagnostics Market Segmental Analysis & Forecast, By End-User, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Hospitals
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Diagnostic Laboratories
7.4 Clinics
7.5 Research Institutes
7.6 Others
8. Infectious Disease Diagnostics Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Direct Sales
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Online Channels
8.4 Distributors
8.5 Others
9. Infectious Disease Diagnostics Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Infectious Disease Diagnostics Market Size & Forecast, By Technology, 2022 – 2035
9.2.3 Infectious Disease Diagnostics Market Size & Forecast, By Disease Type, 2022 – 2035
9.2.4 Infectious Disease Diagnostics Market Size & Forecast, By End-User, 2022 – 2035
9.2.5 Infectious Disease Diagnostics Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.2.6 Infectious Disease Diagnostics Market Size & Forecast, By Country, 2022 – 2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Infectious Disease Diagnostics Market Size & Forecast, By Technology, 2022 – 2035
9.3.3 Infectious Disease Diagnostics Market Size & Forecast, By Disease Type, 2022 – 2035
9.3.4 Infectious Disease Diagnostics Market Size & Forecast, By End-User, 2022 – 2035
9.3.5 Infectious Disease Diagnostics Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.3.6 Infectious Disease Diagnostics Market Size & Forecast, By Country, 2022 – 2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Infectious Disease Diagnostics Market Size & Forecast, By Technology, 2022 – 2035
9.4.3 Infectious Disease Diagnostics Market Size & Forecast, By Disease Type, 2022 – 2035
9.4.4 Infectious Disease Diagnostics Market Size & Forecast, By End-User, 2022 – 2035
9.4.5 Infectious Disease Diagnostics Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.4.6 Infectious Disease Diagnostics Market Size & Forecast, By Country, 2022 – 2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Infectious Disease Diagnostics Market Size & Forecast, By Technology, 2022 – 2035
9.5.3 Infectious Disease Diagnostics Market Size & Forecast, By Disease Type, 2022 – 2035
9.5.4 Infectious Disease Diagnostics Market Size & Forecast, By End-User, 2022 – 2035
9.5.5 Infectious Disease Diagnostics Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.5.6 Infectious Disease Diagnostics Market Size & Forecast, By Country, 2022 – 2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Infectious Disease Diagnostics Market Size & Forecast, By Technology, 2022 – 2035
9.6.3 Infectious Disease Diagnostics Market Size & Forecast, By Disease Type, 2022 – 2035
9.6.4 Infectious Disease Diagnostics Market Size & Forecast, By End-User, 2022 – 2035
9.6.5 Infectious Disease Diagnostics Market Size & Forecast, By Distribution Channel, 2022 – 2035
9.6.6 Infectious Disease Diagnostics Market Size & Forecast, By Country, 2022 – 2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 Egypt
9.6.6.5 South Africa
9.6.6.6 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022 – 2035
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Product/Service & Network Type Benchmarking
10.4.1 Product/Service Specifications & Features By Key Players
10.4.2 Product/Service Heatmap By Key Players
10.4.3 Network Type Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Abbott Laboratories
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Product/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 F. Hoffmann-La Roche Ltd
10.6.3 Thermo Fisher Scientific Inc.
10.6.4 Danaher Corporation
10.6.5 bioMérieux SA
10.6.6 Siemens Healthineers AG
10.6.7 Becton, Dickinson and Company
10.6.8 QIAGEN N.V.
10.6.9 Hologic Inc.
10.6.10 Bio-Rad Laboratories, Inc.
10.6.11 QuidelOrtho Corporation
10.6.12 Grifols S.A.
10.6.13 DiaSorin S.p.A.
10.6.14 SD Biosensor, Inc.
10.6.15 PerkinElmer Inc.
10.6.16 Sysmex Corporation
10.6.17 OraSure Technologies, Inc.
10.6.18 Co-Diagnostics, Inc.
10.6.19 Trinity Biotech plc
10.6.20 Genetic Signatures Ltd.
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures